Spanish Menopause Society position statement: Use of denosumab in postmenopausal women.

MLA

Cano, Antonio, et al. “Spanish Menopause Society Position Statement: Use of Denosumab in Postmenopausal Women.” Maturitas, vol. 79, no. 1, Sept. 2014, pp. 117–21. EBSCOhost, https://doi.org/10.1016/j.maturitas.2014.06.011.

APA

Cano, A., Silvan, J. M., Estévez, A., Baró, F., Villero, J., Quereda, F., Ferrer, J., Mendoza, N., & Sánchez-Borrego, R. (2014). Spanish Menopause Society position statement: Use of denosumab in postmenopausal women. Maturitas, 79(1), 117–121. https://doi.org/10.1016/j.maturitas.2014.06.011

Chicago

Cano, Antonio, José Manuel Silvan, Antonio Estévez, Francesc Baró, José Villero, Francisco Quereda, Javier Ferrer, Nicolás Mendoza, and Rafael Sánchez-Borrego. 2014. “Spanish Menopause Society Position Statement: Use of Denosumab in Postmenopausal Women.” Maturitas 79 (1): 117–21. doi:10.1016/j.maturitas.2014.06.011.